Search Results - "OBLADEN, M"

Refine Results
  1. 1

    Characterization of the vitamin A transport in preterm infants after repeated high-dose vitamin A injections by Longardt, A C, Schmiedchen, B, Raila, J, Schweigert, F J, Obladen, M, Bührer, C, Loui, A

    Published in European journal of clinical nutrition (01-12-2014)
    “…Background/Objectives: Preterm infants have low vitamin A stores at birth, and parenteral administration of high-dose vitamin A reduces pulmonary morbidity…”
    Get full text
    Journal Article
  2. 2

    Total serum bilirubin levels during cyclooxygenase inhibitor treatment for patent ductus arteriosus in preterm infants by Rheinlaender, C, Helfenstein, D, Walch, E, Berns, M, Obladen, M, Koehne, P

    Published in Acta Paediatrica (01-01-2009)
    “…Aim: To determine whether ibuprofen use in VLBW infants is associated with increased serum bilirubin levels and impaired neurodevelopmental outcome at 2 years…”
    Get full text
    Journal Article
  3. 3

    Breast milk from mothers of very low birthweight infants: variability in fat and protein content by Weber, A, Loui, A, Jochum, F, Bührer, C, Obladen, M

    Published in Acta Paediatrica (01-07-2001)
    “…While breast milk appears to be superior to formula for the development of very low birthweight (VLBW) infants, it is supplemented to meet the metabolic…”
    Get full text
    Journal Article
  4. 4

    Development of a surveillance system for nosocomial infections: the component for neonatal intensive care units in Germany by Gastmeier, P., Geffers, C., Schwab, F., Fitzner, J., Obladen, M., Rüden, H.

    Published in The Journal of hospital infection (01-06-2004)
    “…Neonates are at high risk of nosocomial infections and surveillance has been shown to be valuable for the reduction of nosocomial infections. The National…”
    Get full text
    Journal Article
  5. 5

    Neurodevelopmental outcome after COX inhibitor treatment for patent ductus arteriosus by Rheinlaender, C, Helfenstein, D, Pees, C, Walch, E, Czernik, C, Obladen, M, Koehne, P

    Published in Early human development (01-02-2010)
    “…Abstract Aim To compare neurodevelopmental results in very low birth weight (VLBW) infants two years after successful or failed cyclooxygenase inhibitor…”
    Get full text
    Journal Article
  6. 6

    Selenium status in term and preterm infants during the first months of life by Loui, A, Raab, A, Braetter, P, Obladen, M, De Braetter, V.N

    Published in European journal of clinical nutrition (01-03-2008)
    “…Objective: We hypothesized that very low birth weight (VLBW) infants have reduced serum and red blood cell (RBC) selenium (Se) at birth, which decrease further…”
    Get full text
    Journal Article
  7. 7

    Growth and neurodevelopmental outcome of very low birthweight infants with necrotizing enterocolitis by Sonntag, J, Grimmer, I, Scholz, T, Metze, B, Wit, J, Obladen, M

    Published in Acta Paediatrica (01-05-2000)
    “…The aim of the study was to assess the effect of necrotizing enterocolitis (NEC) on neurodevelopmental outcome and growth. Neurodevelopmental outcome of 20 out…”
    Get full text
    Journal Article
  8. 8

    Neonatal end-of-life practice in a German perinatal centre by Schulz-Baldes, A, Huseman, D, Loui, A, Dudenhausen, JW, Obladen, M

    Published in Acta Paediatrica (01-05-2007)
    “…Aim: To investigate the end‐of‐life practice in a large perinatal centre in Germany. Methods: Retrospective chart review was performed in all neonates deceased…”
    Get full text
    Journal Article
  9. 9

    Growth in high risk infants < 1500 g birthweight during the first 5 weeks by Loui, A, Tsalikaki, E, Maier, K, Walch, E, Kamarianakis, Y, Obladen, M

    Published in Early human development (01-10-2008)
    “…Abstract Background Growth of very low birthweight (VLBW) infants is used to monitor nutrition and intrauterine velocity is taken as the desired goal. Aim We…”
    Get full text
    Journal Article
  10. 10

    Bilateral agenesis of the superior vena cava associated with congenital hydrothorax by Römer, S., Opgen‐Rhein, B., Chaoui, R., Scheer, I., Czernik, C., Obladen, M.

    Published in Ultrasound in obstetrics & gynecology (01-11-2006)
    “…Agenesis of the superior vena cava is a rare anomaly that is generally asymptomatic in the neonate. We report a male neonate with bilateral (total) agenesis of…”
    Get full text
    Journal Article
  11. 11

    Harlequin ichthyosis--medical and psychosocial challenges by Eilers, E, Stieler, K, Thies, C, Blume-Peytavi, U, Obladen, M, Hüseman, D

    Published in Klinische Padiatrie (01-03-2010)
    “…Harlequin ichthyosis is the most severe congenital keratinizing disorder. It is caused by mutations in the ABCA12 gene leading to defective lipid transport…”
    Get more information
    Journal Article
  12. 12

    Use of 2% 2-phenoxyethanol and 0.1% octenidine as antiseptic in premature newborn infants of 23–26 weeks gestation by Bührer, C., Bahr, S., Siebert, J., Wettstein, R., Geffers, C., Obladen, M.

    Published in The Journal of hospital infection (01-08-2002)
    “…In preterm newborn infants, topical iodine-containing antiseptics disturb thyroid hormone regulation while alcohol-based disinfectants may cause local burns…”
    Get full text
    Journal Article
  13. 13
  14. 14

    The CRIB (Clinical Risk Index for Babies) score and neurodevelopmental impairment at one year corrected age in very low birth weight infants by Bührer, C, Grimmer, I, Metze, B, Obladen, M

    Published in Intensive care medicine (01-03-2000)
    “…To assess the ability of the Clinical Risk Index for Babies (CRIB) to predict long-term neurodevelopmental impairment in very low birth weight (VLBW) infants…”
    Get full text
    Journal Article
  15. 15
  16. 16

    High- versus low-dose erythropoietin in extremely low birth weight infants by Maier, Rolf F., Obladen, Michael, Kattner, Evelyn, Natzschka, Jürgen, Messer, Jean, Regazzoni, Bianca M., Speer, Christian P., Fellman, Vineta, Grauel, E.Ludwig, Groneck, Peter, Wagner, Martin, Moriette, Guy, Salle, Bernard L., Verellen, Gaston, Scigalla, Paul

    Published in The Journal of pediatrics (01-05-1998)
    “…Objective: To investigate whether a weekly 1500 IU/kg dose of recombinant human erythropoietin (rhEPO) is more effective than a dose of 750 IU/kg/week in…”
    Get full text
    Journal Article
  17. 17

    Neurodevelopmental outcome after prenatal exposure to opiates by BUNIKOWSKI, R, GRIMMER, I, HEISER, A, METZE, B, SCHÄFER, A, OBLADEN, M

    Published in European journal of pediatrics (01-09-1998)
    “…To study the developmental effects of prenatal exposure to opiates, a prospective follow up study of 34 drug-exposed (opiates and nicotine) and 42 reference…”
    Get full text
    Journal Article
  18. 18

    Patent ductus arteriosus in very low birthweight infants: complications of pharmacological and surgical treatment by Koehne, P S, Bein, G, Alexi-Meskhishvili, V, Weng, Y, Bührer, C, Obladen, M

    Published in Journal of perinatal medicine (01-01-2001)
    “…To evaluate complications of surgical and pharmacological treatment of symptomatic patent ductus arteriosus (PDA) in very low birthweight (VLBW) infants. Of…”
    Get more information
    Journal Article
  19. 19

    Calcium, phosphorus and magnesium balance: FM 85 fortification of human milk does not meet mineral needs of extremely low birthweight infants by LOUI, A, RAAB, A, OBLADEN, M, BRÄTTER, P

    Published in European journal of clinical nutrition (01-03-2002)
    “…Extremely low birthweight (<1000 g) infants are growing rapidly and their nutritional requirements for calcium, phosphorus, magnesium are high. Prospective,…”
    Get full text
    Journal Article
  20. 20